Durham, NC, United States of America

Charlene L Burns

This inventor holds 5 USPTO granted patents. Top assignees: Glaxo Wellcome Inc., Burroughs Wellcome Co.. Active years: 1991-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charlene L Burns. Retrieved from https://idiyas.com/inventor/charlene-l-burns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1991-1997

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charlene L. Burns

Introduction: Charlene L. Burns is a prominent inventor based in Durham, North Carolina. With a remarkable portfolio of five patents to her name, she has made significant contributions to the field of therapeutic nucleosides. Her work demonstrates a commitment to advancing medical science through innovative solutions.

Latest Patents: Among her latest inventions are the patents for 2',3'-dideoxy-3'-fluoro-purine ribonucleosides and therapeutic nucleosides. These innovations reflect her ingenuity and dedication to developing novel compounds that hold promise for medical applications.

Career Highlights: Charlene has had an impactful career, working with esteemed companies such as Glaxo Wellcome Inc. and Burroughs Wellcome Co. Her experience in these leading pharmaceutical firms has enriched her expertise and fueled her inventive spirit.

Collaborations: Throughout her career, Charlene has collaborated with notable colleagues, including George Walter Koszalka and Thomas A. Krenitsky. These partnerships have played a vital role in her research and development efforts, fostering an environment of creativity and progress.

Conclusion: Charlene L. Burns stands out as a remarkable inventor whose work has the potential to make a significant impact in the field of medical science. Her contributions to therapeutic nucleosides, along with her collaborations and career achievements, underscore her dedication to innovation and improvement in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…